Short answer
Waters Corporation (WAT) filed its Q4 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Oct 3, 2026. Quarterly revenue was $1.8B (up 120.8% year over year) with net income of $81M.
Q4 2026 key financials · XBRL
- Revenue
- $1.8B
- +120.8% YoY · +7.4% QoQ
- Net income
- $81M
- −45.6% YoY · +159.6% QoQ
- Operating margin
- 7.2%
- EPS (diluted)
- $0.94
- −62.4% YoY · +165.3% QoQ
Source: XBRL data from the Waters Corporation (WAT) Q4 2026 10-Q on SEC EDGAR. USD.
Waters Corporation Q4 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Third-quarter revenue $1,767M, up 121% YoY, including $896M from BDS Business
- Operating margin 7.2% vs 24.0% YoY, pressured by $232M amortization and acquisition-related costs
- Best segment: Biosciences, $396M revenue and 36.6% operating margin
- Worst segment: Advanced Diagnostics, 26.4% operating margin versus Analytical & Materials Sciences at 35.3%
- Operating cash flow $315M vs $488M YoY, with $150M capital expenditures and $5.1B outstanding debt
- Near-term headwinds: tariffs, supply-chain disruption, integration execution, government funding reductions and China market uncertainty
Risk Factors
- No material changes to 10-K risk factors as of October 3, 2026
- Forward-looking statement risks highlighted in Part I, Item 2
- Unidentified or currently immaterial risks could materially affect business, financial condition, and operating results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Waters Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.